Literature DB >> 1762805

Treatment outcome in a multidisciplinary cancer pain clinic.

A Banning1, P Sjøgren, H Henriksen.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1762805     DOI： 10.1016/0304-3959(91)90195-4

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  16 in total

Review 1.  Substance abuse in cancer pain.

Authors:  Tatiana D Starr; Lauren J Rogak; Steven D Passik
Journal:  Curr Pain Headache Rep       Date:  2010-08

Review 2.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Recent advances: oncology.

Authors:  M H Tattersall; H Thomas
Journal:  BMJ       Date:  1999-02-13

4.  Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain.

Authors:  P W Wacnik; L J Eikmeier; T R Ruggles; M L Ramnaraine; B K Walcheck; A J Beitz; G L Wilcox
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

5.  New frontier: cancer pain management clinical fellowship.

Authors:  Uri Hochberg; Jordi Perez; Manuel Borod
Journal:  Support Care Cancer       Date:  2018-02-10       Impact factor: 3.603

6.  Incident pain and analgesic consumption decrease after samarium infusion: a pilot study.

Authors:  Carla Ripamonti; Elena Fagnoni; Tiziana Campa; Ettore Seregni; Marco Maccauro; Emilio Bombardieri
Journal:  Support Care Cancer       Date:  2006-09-12       Impact factor: 3.603

7.  Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study.

Authors:  Carla Ripamonti; Elena Fagnoni; Tiziana Campa; Vincenzo Giardina; Cinzia Brunelli; Alessandra Pigni; Franco De Conno
Journal:  Support Care Cancer       Date:  2007-03-01       Impact factor: 3.603

8.  Interleukin 1beta facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation.

Authors:  R-X Zhang; B Liu; A Li; L Wang; K Ren; J-T Qiao; B M Berman; L Lao
Journal:  Neuroscience       Date:  2008-05-07       Impact factor: 3.590

Review 9.  New developments in the assessment of pain in cancer patients.

Authors:  E Bruera; S Watanabe
Journal:  Support Care Cancer       Date:  1994-09       Impact factor: 3.603

Review 10.  The challenges of cancer pain assessment and management.

Authors:  Clare Shute
Journal:  Ulster Med J       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.